The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines.

[1]  P. Zawierucha,et al.  Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies , 2020, International journal of molecular sciences.

[2]  M. Ruchała,et al.  Adropin Stimulates Proliferation and Inhibits Adrenocortical Steroidogenesis in the Human Adrenal Carcinoma (HAC15) Cell Line , 2020, Frontiers in Endocrinology.

[3]  A. Gdowicz-Kłosok,et al.  Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity , 2020, Cellular Signalling.

[4]  H-B Cai,et al.  IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  D. Matei,et al.  Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer , 2019, npj Precision Oncology.

[6]  P. Zawierucha,et al.  The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells , 2019, Biomolecules.

[7]  M. Nowicki,et al.  Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines , 2019, International journal of molecular sciences.

[8]  M. Nowicki,et al.  PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations , 2019, International journal of molecular sciences.

[9]  M. Nowicki,et al.  Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development , 2018, International journal of molecular sciences.

[10]  M. Nowicki,et al.  The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines , 2018, International journal of molecular sciences.

[11]  M. Nowicki,et al.  New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines , 2018, Molecules.

[12]  N. Yanaihara,et al.  Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  M. Nowicki,et al.  New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines , 2017, Molecules.

[14]  M. Nowicki,et al.  The significance of lumican expression in ovarian cancer drug-resistant cell lines , 2017, Oncotarget.

[15]  M. Nowicki,et al.  Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines , 2017, Oncotarget.

[16]  M. Nowicki,et al.  New and Old Genes Associated with Topotecan Resistance Development in Ovarian Cancer Cell Lines. , 2017, Anticancer research.

[17]  M. Nowicki,et al.  Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines , 2016, Journal of Ovarian Research.

[18]  Shufeng Zhou,et al.  Molecular mechanisms for tumour resistance to chemotherapy , 2016, Clinical and experimental pharmacology & physiology.

[19]  C. Annunziata,et al.  Characterization of ovarian cancer cell lines as in vivo models for preclinical studies. , 2016, Gynecologic oncology.

[20]  D. Choubey,et al.  IFI16, an amplifier of DNA-damage response: Role in cellular senescence and aging-associated inflammatory diseases , 2016, Ageing Research Reviews.

[21]  D. Choubey,et al.  Bisphenol A (BPA) stimulates the interferon signaling and activates the inflammasome activity in myeloid cells , 2015, Molecular and Cellular Endocrinology.

[22]  E. Colvin,et al.  The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle , 2015, Front. Oncol..

[23]  S. Paludan,et al.  IFI16: At the interphase between innate DNA sensing and genome regulation. , 2014, Cytokine & growth factor reviews.

[24]  Henry C Kitchener,et al.  Ovarian cancer , 2014, The Lancet.

[25]  R. Kuang,et al.  Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment , 2013, Front. Oncol..

[26]  K. Borden,et al.  Mechanisms and insights into drug resistance in cancer , 2013, Front. Pharmacol..

[27]  M. Nowicki,et al.  Inhibitors of N-glycosylation as a potential tool for analysis of the mechanism of action and cellular localisation of glycoprotein P. , 2012, Acta biochimica Polonica.

[28]  Eva Z. Curley,et al.  The mammalian PYHIN gene family: Phylogeny, evolution and expression , 2012, BMC Evolutionary Biology.

[29]  I. Cristea,et al.  Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16 , 2012, Proceedings of the National Academy of Sciences.

[30]  Mina J Bissell,et al.  The tumor microenvironment is a dominant force in multidrug resistance. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[31]  Christian Marth,et al.  2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer: Report From the Fourth Ovarian Cancer Consensus Conference , 2011, International Journal of Gynecologic Cancer.

[32]  Yun-Xing Wang,et al.  Interferon-inducible protein 16: insight into the interaction with tumor suppressor p53. , 2011, Structure.

[33]  S. Landolfo,et al.  The multifaceted interferon-inducible p200 family proteins: from cell biology to human pathology. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[34]  A. Bowie,et al.  IFI16 is an innate immune sensor for intracellular DNA , 2010, Nature Immunology.

[35]  D. Choubey,et al.  Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[36]  P. Caposio,et al.  The interferon‐inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response , 2010, European journal of immunology.

[37]  J. Fletcher,et al.  ABC transporters in cancer: more than just drug efflux pumps , 2010, Nature Reviews Cancer.

[38]  Xin Duan,et al.  Interferon-Inducible IFI16, a Negative Regulator of Cell Growth, Down-Regulates Expression of Human Telomerase Reverse Transcriptase (hTERT) Gene , 2010, PloS one.

[39]  Jessica E. Bolden,et al.  Inducible activation of IFI 16 results in suppression of telomerase activity, growth suppression and induction of cellular senescence , 2009, Journal of cellular biochemistry.

[40]  B. Hennessy,et al.  Ovarian cancer , 2009, The Lancet.

[41]  F. Alimirah,et al.  Expression of an IFN-Inducible Cellular Senescence Gene, IFI16, Is Up-Regulated by p53 , 2008, Molecular Cancer Research.

[42]  M. Stauch,et al.  Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  D. Katsaros,et al.  Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  E. Medico,et al.  A Novel Role of the Interferon-inducible Protein IFI16 as Inducer of Proinflammatory Molecules in Endothelial Cells* , 2007, Journal of Biological Chemistry.

[45]  R. Lothe,et al.  Improved gene expression signature of testicular carcinoma in situ. , 2007, International journal of andrology.

[46]  F. Alimirah,et al.  IFI16 in Human Prostate Cancer , 2007, Molecular Cancer Research.

[47]  J. W. Kim,et al.  Identification of genes with differential expression in chemoresistant epithelial ovarian cancer using high-density oligonucleotide microarrays. , 2006, Oncology research.

[48]  F. Alimirah,et al.  Androgen receptor auto‐regulates its expression by a negative feedback loop through upregulation of IFI16 protein , 2006, FEBS letters.

[49]  K. Horwitz,et al.  Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture. , 2006, Endocrinology.

[50]  R. Ochs,et al.  Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells , 2005, Molecular Cancer Therapeutics.

[51]  R. Johnstone,et al.  The HIN-200 family: more than interferon-inducible genes? , 2005, Experimental cell research.

[52]  Thomas Lengauer,et al.  The HIN domain of IFI-200 proteins consists of two OB folds. , 2005, Biochemical and biophysical research communications.

[53]  B. Nelkin,et al.  IFI16 Is an Essential Mediator of Growth Inhibition, but Not Differentiation, Induced by the Leukemia Inhibitory Factor/JAK/STAT Pathway in Medullary Thyroid Carcinoma Cells* , 2005, Journal of Biological Chemistry.

[54]  S. Landolfo,et al.  Altered patterns of the interferon‐inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index , 2004, Histopathology.

[55]  O. Pereira-smith,et al.  Role of IFI 16 in cellular senescence of human fibroblasts , 2004, Oncogene.

[56]  N. Fujiuchi,et al.  Requirement of IFI16 for the Maximal Activation of p53 Induced by Ionizing Radiation* , 2004, Journal of Biological Chemistry.

[57]  Casey C. Fowler,et al.  Regulation of ultraviolet light-induced gene expression by gene size. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Cameron,et al.  Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. , 2004, The American journal of pathology.

[59]  Edison T Liu,et al.  Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts. , 2004, Molecular cancer therapeutics.

[60]  P. Ongusaha,et al.  IFI16 as a Negative Regulator in the Regulation of p53 and p21Waf1* , 2003, Journal of Biological Chemistry.

[61]  R. Johnstone,et al.  Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence , 2003, Oncogene.

[62]  V. Torri,et al.  Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial , 2003, The Lancet.

[63]  G. Voglino,et al.  Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[64]  J. DeGregori,et al.  The genetics of the E2F family of transcription factors: shared functions and unique roles. , 2002, Biochimica et biophysica acta.

[65]  J. Trapani,et al.  Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16 , 2000, Oncogene.

[66]  J. Harbour,et al.  The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.

[67]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[68]  J. Trapani,et al.  Isotypic variants of the interferon-inducible transcriptional repressor IFI 16 arise through differential mRNA splicing. , 1998, Biochemistry.

[69]  S. Landolfo,et al.  The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response. , 2015, The new microbiologica.

[70]  D. Choubey,et al.  Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization. , 2012, Molecular immunology.

[71]  D. Choubey,et al.  Interferon-inducible IFI16 protein in human cancers and autoimmune diseases. , 2008, Frontiers in bioscience : a journal and virtual library.

[72]  R. Eddy,et al.  A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-γ in myeloid cells , 2004, Immunogenetics.

[73]  J. Trapani,et al.  Expression of IFI 16 in epithelial cells and lymphoid tissues , 2002, Histochemistry and Cell Biology.